News Focus
News Focus
Replies to #99387 on Biotech Values
icon url

DewDiligence

07/23/10 12:28 PM

#99394 RE: bxjwn9ru #99387

The consequential immediate uncertainty is not so much about Teva, but rather is whether SNY will launch an authorized generic.